Found 7 matching trials
Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis PHASE3 The purpose of this study is to assess the effects of zoledronic acid admin...
Show More Location
Multiple Locations
Learn More & Join Trial
THAL-DEX Incorporated Into Double PBSC Autotransplantation for Untreated Multiple Myeloma (MM) PHASE2 The marked activity of thalidomide (thal) and dexamethasone (dex) in relaps...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy in Reducing Fractures and Safety of Zoledronic Acid in Men With Osteoporosis PHASE3 This study will investigate if the drug zoledronic acid given once yearly i...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial PHASE3 This is an open-label, multicenter, 2x2 factorial design, randomized contro...
Show More Location
Klinikum der Universität München, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Campus Innenstadt
Learn More & Join Trial
Changes of GCF Levels of RANKL and Osteoprotegerin in Postmenopausal Osteoporosis PHASE4 The investigators evaluated the effect of initial periodontal treatment on ...
Show More Location
Multiple Locations
Learn More & Join Trial
Zoledronic Acid in the Prevention of Bone Loss in Postmenopausal Women With Osteopenia, 45 Years of Age and Older PHASE3 Osteoporosis prevention is important in patients with osteopenia (low bone ...
Show More Location
For information regarding facilities, please contact the Central Contact
Learn More & Join Trial
1 Year Open-label Extension to CZOL446H2337 Safety and Efficacy Trial of Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids PHASE3 This 1-year open-label extension to CZOL446H2337 is designed to evaluate th...
Show More Location
Novartis Investigative Site
Learn More & Join Trial